About Biosensors International
Biosensors International is a company based in Singapore (Singapore) founded in 1990 by Yoh Chie Lu was acquired by CPE in November 2015.. Biosensors International has completed 1 acquisition, including Spectrum Dynamics. Biosensors International operates in a competitive market with competitors including SMT, InspireMD, Vesper Medical, Endospan and Veryan Medical, among others.
- Headquarter Singapore, Singapore
- Founders Yoh Chie Lu
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biosensors Medical India Private Limited
- Date of Incorporation 17 Oct, 2019
- Jurisdiction Pune City, Maharashtra, India
-
Annual Revenue
$484.65 K (USD)61.73as on Mar 31, 2023
-
Net Profit
$28.16 K (USD)253.77as on Mar 31, 2023
-
EBITDA
$38.94 K (USD)92.63as on Mar 31, 2023
-
Latest Funding Round
$15 M (USD), Post-IPO
Jan 05, 2007
-
Investors
Three Arch Partners
& 3 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
CPE
(Nov 04, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Biosensors International
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $15.0M
-
First Round
First Round
(05 Jan 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2007 | Amount | Post-IPO - Biosensors International | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biosensors International
Biosensors International has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Three Arch Partners, GGV Capital and Evolution Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science & tech focused VC firm investing in companies in the US
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location | |
|
Small-business private equity firm is focused on growth support.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biosensors International
Biosensors International has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Spectrum Dynamics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cardiac imaging systems are manufactured using advanced molecular technologies.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biosensors International
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biosensors International Comparisons
Competitors of Biosensors International
Biosensors International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SMT, InspireMD, Vesper Medical, Endospan and Veryan Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
SMT is recognized as a developer of cardiovascular medical devices.
|
|
| domain | founded_year | HQ Location |
Proprietary stent systems with bio-stable mesh are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Venous stent system is developed for deep vein disease treatment.
|
|
| domain | founded_year | HQ Location |
Endovascular stent graft systems for aortic aneurysm repair are developed.
|
|
| domain | founded_year | HQ Location |
Three-dimensional vascular stents for peripheral vascular disease are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biosensors International
Frequently Asked Questions about Biosensors International
When was Biosensors International founded?
Biosensors International was founded in 1990 and raised its 1st funding round 17 years after it was founded.
Where is Biosensors International located?
Biosensors International is headquartered in Singapore, Singapore.
What is the annual revenue of Biosensors International?
Annual revenue of Biosensors International is $484.65K as on Mar 31, 2023.
What does Biosensors International do?
Biosensors International develops medical devices used in interventional cardiology and critical care procedures. Their product offerings include drug-eluting stents, drug coated stents, bare metal stents and angioplasty catheters for the treatment of coronary artery disease. They also offer stenting and ballooning solutions for peripheral arterial diseases. Biosensors International was acquired by Citic Group in 2015.
Who are the top competitors of Biosensors International?
How many acquisitions has Biosensors International made?
Biosensors International has made 1 acquisition, including Spectrum Dynamics.
Who are Biosensors International's investors?
Biosensors International has 4 investors. Key investors include Three Arch Partners, GGV Capital, Evolution Capital Partners, and CPE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.